Phase III Randomised Study on Liposomal Cytarabine (DepoCyte) vs. Intrathecal Triple for CNS-Treatment During Maintenance Therapy in High-Risk Acute Lymphoblastic Leukemia Patients in NOPHO ALL 2008 Treatment Protocol.

Next Previous
Trial Profile

Phase III Randomised Study on Liposomal Cytarabine (DepoCyte) vs. Intrathecal Triple for CNS-Treatment During Maintenance Therapy in High-Risk Acute Lymphoblastic Leukemia Patients in NOPHO ALL 2008 Treatment Protocol.

Suspended
Phase of Trial: Phase III

Latest Information Update: 02 May 2016

At a glance

  • Drugs Cytarabine (Primary) ; Asparaginase; Dexamethasone; Mercaptopurine; Methotrexate; Prednisolone sodium succinate
  • Indications Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Therapeutic Use

    • Most Recent Events

    • 02 May 2016 This trial is 'prematurely ended' in Lithuania, according to European Clinical Trials Database.
    • 17 Mar 2012 Additional location (Lithuania) added and additional lead trial centre identified as reported by European Clinical Trials Database record.
    • 20 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top